Biography:
Garima Joshi, a Ph.D. scholar at the Regional Centre for Biotechnology (RCB). She works as a senior research fellow, and her research focuses on combating post-acute COVID-19 complications, especially pulmonary inflammation and fibrosis, through alpha-ketoglutarate supplementation. To drive this forward, she developed a unique SARS-CoV-2-induced ARDS mice model, enabling new insights. With four publications—three research articles and a review—she is committed to advancing science and sharing findings. She actively engage in scientific conferences, including the IUBMB RNA virus meeting (2022) and a human microbiome conference with a next-generation sequencing workshop (2023). These events have enriched her research perspective and facilitated valuable professional connections.
Title : Promising therapeutic intervention: Dietary supplementation with alphaKG reduces pulmonary fibrosis and ARDS pathogenesis in SARS-CoV-2-infected mice